ATE381341T1 - Präventive wirkungen von morinda citrifolia auf brustkrebs - Google Patents
Präventive wirkungen von morinda citrifolia auf brustkrebsInfo
- Publication number
- ATE381341T1 ATE381341T1 AT04817748T AT04817748T ATE381341T1 AT E381341 T1 ATE381341 T1 AT E381341T1 AT 04817748 T AT04817748 T AT 04817748T AT 04817748 T AT04817748 T AT 04817748T AT E381341 T1 ATE381341 T1 AT E381341T1
- Authority
- AT
- Austria
- Prior art keywords
- morinda citrifolia
- present
- breast cancer
- puree
- mammary
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/746—Morinda
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/639,833 US20050037101A1 (en) | 2003-08-12 | 2003-08-12 | Preventative effects of morinda citrifolia on mammary breast cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE381341T1 true ATE381341T1 (de) | 2008-01-15 |
Family
ID=34135957
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT04817748T ATE381341T1 (de) | 2003-08-12 | 2004-08-11 | Präventive wirkungen von morinda citrifolia auf brustkrebs |
Country Status (12)
Country | Link |
---|---|
US (1) | US20050037101A1 (de) |
EP (1) | EP1654003B1 (de) |
JP (1) | JP2007502299A (de) |
CN (1) | CN1832759A (de) |
AT (1) | ATE381341T1 (de) |
AU (1) | AU2004291030B2 (de) |
BR (1) | BRPI0413494A (de) |
CA (1) | CA2533884A1 (de) |
DE (1) | DE602004010818T2 (de) |
MX (1) | MXPA06001651A (de) |
RU (1) | RU2346700C2 (de) |
WO (1) | WO2005048919A2 (de) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8652546B2 (en) | 2007-09-06 | 2014-02-18 | Tahitian Noni International, Inc. | Morinda citrifolia based formulations for regulating T cell immunomodulation in neonatal stock animals |
US6855345B2 (en) * | 2001-11-02 | 2005-02-15 | Morinda, Inc. | Preventative and treatment effects of Morinda citrifolia on diabetes and its related conditions |
US8790727B2 (en) * | 2000-12-05 | 2014-07-29 | Tahitian Noni International, Inc. | Morinda citrifolia and iridoid based formulations |
US20110217394A1 (en) * | 2000-12-05 | 2011-09-08 | Brett Justin West | Iridoid Based Formulations |
US8574642B2 (en) | 2000-12-05 | 2013-11-05 | Tahitian Noni International, Inc. | Antiviral Morinda citrifolia L. based formulations and methods of administration |
US20110171333A1 (en) * | 2000-12-05 | 2011-07-14 | Bryant Wadsworth | Morinda Citrifolia Based Antioxidant and Antimicrobial Formulations for Improved Color Stability and Increased Shelf Life of Various Meat Products |
US20040192761A1 (en) * | 2003-03-25 | 2004-09-30 | Palu Afa Kehaati | Preventative and treatment effects of morinda citrifolia as an aromatase inhibitor |
US20110160057A1 (en) * | 2001-11-14 | 2011-06-30 | Bryant Wadsworth | Morinda Citrifolia Based Antimicrobial Formulations |
US7442395B2 (en) * | 2002-11-14 | 2008-10-28 | Tahitian Noni International, Inc. | Formulation for treating candidiasis using Morinda citrifolia |
JP4073826B2 (ja) * | 2003-06-04 | 2008-04-09 | タヒチアン ノニ インターナショナル インコーポレーテッド | ヤエヤマアオキの抽出物を含む農業用活力剤 |
US20070259060A1 (en) * | 2003-08-12 | 2007-11-08 | Mian-Ying Wang | Formulations and Methods for Treating Breast Cancer with Morinda Citrifolia and Methylsulfonymethane |
US20060204601A1 (en) * | 2005-03-09 | 2006-09-14 | Palu Afa K | Formulations and methods for preventing and treating substance abuse and addiction |
US20070122507A1 (en) * | 2005-05-26 | 2007-05-31 | Palu Afa K | Histone deacetylase and tumor necrosis factor converting enzyme inhibition |
US20060280818A1 (en) * | 2005-05-26 | 2006-12-14 | Palu Afa K | Nicotinic acetylcholine receptor antagonist |
US20070184137A1 (en) * | 2005-11-29 | 2007-08-09 | Palu Afa K | Morinda Citrifolia L. Based Formulations for Inhibiting Matrix Metalloproteinase Enzymes |
US20070154579A1 (en) * | 2005-11-29 | 2007-07-05 | Palu Afa K | Morinda Citrifolia Based Formulation And Methods For Weight Management |
US20070166417A1 (en) * | 2005-11-29 | 2007-07-19 | Palu Afa K | Formulation and Methods for Use of Morinda Citrifolia Seed Oil |
US20070281903A1 (en) * | 2006-05-04 | 2007-12-06 | Palu Afa K | Morinda Citrifolia-Based Formulation 5-LOX And 15-LOX |
US8025910B2 (en) | 2006-05-12 | 2011-09-27 | Tahitian Noni International, Inc. | Method and composition for administering bioactive compounds derived from Morinda citrifolia |
US8535741B2 (en) | 2006-05-12 | 2013-09-17 | Morinda, Inc. | Method and composition for administering bioactive compounds derived from Morinda citrifolia |
US20080317890A1 (en) * | 2007-06-21 | 2008-12-25 | Claude Jarakae Jensen | Method for treating visual impairment through the prophylactic administration of a morinda citrifolia-based naturaceutical |
US20090196944A1 (en) * | 2008-02-01 | 2009-08-06 | Brad Rawson | Methods of Manufacture of Morinda Citrifolia Based Compositions for Treatment of Anti-Inflammatory Diseases through Inhibition of Cox-1, Cox-2, Interleukin -1beta, Interleukin-6, TNF-alpha, HLE, and iNOS |
US20110206786A1 (en) * | 2010-02-23 | 2011-08-25 | Brett Justin West | Acai and Iridoid Based Formulations |
RU2676437C1 (ru) * | 2018-01-09 | 2018-12-28 | федеральное государственное бюджетное образовательное учреждение высшего образования "Башкирский государственный медицинский университет" Министерства здравоохранения Российской Федерации | Способ моделирования проканцерогенного действия синестрола на яичники потомства женского пола у лабораторных мышей |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5071878A (en) * | 1979-08-30 | 1991-12-10 | Herschler R J | Use of methylsulfonylmethane to enhance diet of an animal |
JPH0687736A (ja) * | 1992-09-07 | 1994-03-29 | Kazuo Umezawa | 抗癌剤 |
US6428816B1 (en) * | 1994-04-08 | 2002-08-06 | Cognis Australia Pty., Ltd. | Carotenoid agent for inhibiting the conversion of epithelial cells to tumors |
US6429204B1 (en) * | 1997-01-15 | 2002-08-06 | University Of Miami | Method of inhibiting cancer growth |
FR2783137A1 (fr) * | 1998-09-10 | 2000-03-17 | Royal Tahiti Noni | Composition a base d'extraits de morinda citrifolia |
US6737089B2 (en) * | 1999-08-27 | 2004-05-18 | Morinda, Inc. | Morinda citrifolia (Noni) enhanced animal food product |
US6254913B1 (en) * | 1999-08-27 | 2001-07-03 | Morinda, Inc. | Morinda citrifolia dietary fiber and method |
EP1347769A4 (de) * | 2000-12-05 | 2008-02-20 | Tahitian Noni Int Inc | Krebsverhütende wirkung von morinda citrifolia |
WO2002083159A1 (en) * | 2001-04-17 | 2002-10-24 | Morinda, Inc. | Palliative effects of morinda citrifolia oil and juice |
-
2003
- 2003-08-12 US US10/639,833 patent/US20050037101A1/en not_active Abandoned
-
2004
- 2004-08-11 BR BRPI0413494-0A patent/BRPI0413494A/pt not_active IP Right Cessation
- 2004-08-11 AU AU2004291030A patent/AU2004291030B2/en not_active Ceased
- 2004-08-11 JP JP2006523390A patent/JP2007502299A/ja not_active Withdrawn
- 2004-08-11 WO PCT/US2004/026253 patent/WO2005048919A2/en active IP Right Grant
- 2004-08-11 EP EP04817748A patent/EP1654003B1/de not_active Not-in-force
- 2004-08-11 CN CNA2004800228402A patent/CN1832759A/zh active Pending
- 2004-08-11 CA CA002533884A patent/CA2533884A1/en not_active Abandoned
- 2004-08-11 MX MXPA06001651A patent/MXPA06001651A/es active IP Right Grant
- 2004-08-11 DE DE602004010818T patent/DE602004010818T2/de active Active
- 2004-08-11 RU RU2006107556/14A patent/RU2346700C2/ru not_active IP Right Cessation
- 2004-08-11 AT AT04817748T patent/ATE381341T1/de active
Also Published As
Publication number | Publication date |
---|---|
CA2533884A1 (en) | 2005-06-02 |
DE602004010818T2 (de) | 2008-12-11 |
MXPA06001651A (es) | 2006-08-11 |
EP1654003A2 (de) | 2006-05-10 |
EP1654003B1 (de) | 2007-12-19 |
AU2004291030A1 (en) | 2005-06-02 |
AU2004291030B2 (en) | 2007-09-20 |
BRPI0413494A (pt) | 2006-10-17 |
US20050037101A1 (en) | 2005-02-17 |
WO2005048919A2 (en) | 2005-06-02 |
DE602004010818D1 (de) | 2008-01-31 |
CN1832759A (zh) | 2006-09-13 |
WO2005048919A3 (en) | 2005-08-11 |
EP1654003A4 (de) | 2006-08-16 |
RU2346700C2 (ru) | 2009-02-20 |
JP2007502299A (ja) | 2007-02-08 |
RU2006107556A (ru) | 2006-08-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE381341T1 (de) | Präventive wirkungen von morinda citrifolia auf brustkrebs | |
WO2004098514A3 (en) | Morinda citrifolia-based formulation for inhibiting metastasis of carcinogenic cells | |
Li et al. | Phlorotannins as bioactive agents from brown algae | |
WO2005067489A3 (en) | Type ii diabetes | |
AR048181A1 (es) | Composicion de ingredientes funcionales | |
Kowalczyk et al. | Insights into novel anticancer applications for apigenin. | |
UA88165C2 (en) | Use of trisubstituted benzopyranones | |
Debnath et al. | Antioxidant potential and oxidative DNA damage preventive activity of Chrysanthemum indicum extracts | |
Tafrihi et al. | Anticancer properties of Teucrium persicum in PC-3 prostate cancer cells | |
TW200531699A (en) | A protectant of periodontal membranes | |
ATE509532T1 (de) | Essbare prdoukte | |
ATE222119T1 (de) | Verwendung von erythropoietin zur behandlung von multiple myelom | |
Jeong et al. | Antioxidant and anticancer properties of methanolic extracts from different parts of white, yellow, and red onion | |
ITMI20021801A1 (it) | Prodotti di pomodoro. | |
TW200637542A (en) | Lipase inhibitor, preventing and treating agent of skin disease | |
WO2007084983A3 (en) | Morinda citrifolia enhanced products for administration to animal | |
CN104082636A (zh) | 一种抗氧化剂组合物 | |
EA200601471A1 (ru) | Ингибиторы клеточной пролиферации клеток (варианты), фармацевтическая композиция на их основе, способ уничтожения раковых клеток (варианты) и способ лечения и профилактики злокачественных состояний (варианты) | |
MX2010005148A (es) | Agentes saborizantes. | |
Shin et al. | Antioxidant properties and total phenolic contents of cherry elaeagnus (Elaeagnus multiflora Thunb.) leaf extracts | |
Chun et al. | Determination of total polyphenol content and antityrosinase capacity of mulberrymedicine (Morusnigra L.) extract | |
Entezari et al. | Evaluation of silibinin on the viability of MCF-7 human breast adenocarcinoma and HUVEC (Human Umbilical Vein Endothelial) cell lines | |
CN107519083A (zh) | 含天然植物提取物的爽肤水 | |
DE602005026694D1 (de) | 2-methylen-19,21-dinor-1alpha-hydroxy-bishomopregnacalciferol | |
CN104082363A (zh) | 一种烘焙食品抗氧化剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1654003 Country of ref document: EP |